Table 5. The prevalence of various genotypes and alleles of rs8192917 in hepatitis patients with and without HCC.
|
rs8192917 |
Without HCC (n=45) |
With HCC (n=40) |
P-value |
OR (95%CI) |
|
Genotypes TT CT CC HWE |
26(57.78%) 14(31.11%) 5(11.11%) 0.170 |
14(35%) 15(37.5%) 11(27.5%) 0.120 |
0.089 0.241 0.031 |
1.0 1.78(0.68-4.71) 3.93(1.13-13.62) |
|
Dominant models TT+CT CC
Recessive model TT CT+CC |
40(88.89%) 5(11.11%)
26(57.78%) 19(42.22%) |
29(72.5%) 11(27.5%)
14(35%) 26(65%) |
0.061
0.037 |
1.0 3.03(0.95-9.68)
1.0 2.54(1.06-6.12) |
|
Alleles T C |
66(73.33%) 24(26.67%) |
43(53.75%) 37(46.25%) |
0.008 |
1.0 2.36(1.25-4.49) |